Valuing a test for the m.1555A>G mitochondrial RNA mutation to prevent deafness in neonates caused by aminoglycoside antibiotic therapy.
Lead Participant:
DIASOLVE LIMITED
Abstract
Awaiting Public Project Summary
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| DIASOLVE LIMITED | £99,000 | £ 99,000 |
Participant |
||
| INNOVATE UK |
People |
ORCID iD |